Role of Immune Cells in Mediating the Effect of Gut Microbiota on Renal Cell Carcinoma
Research Square
2024
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Background The gut microbiota plays a crucial role in the development of various illnesses, including immune-related disorders. However, the potential association between renal cell carcinoma (RCC) and gut microbiota remains underexplored. Methods We utilized data from Genome-Wide Association Studies (GWAS) public databases to perform a bidirectional Mendelian randomization (MR) analysis with two samples, aiming to investigate the causal relationship between gut microbiota and RCC. The primary analysis employed the inverse variance weighted (IVW) method. Extensive sensitivity analyses were conducted to evaluate heterogeneity and horizontal pleiotropy. Additionally, a two-step MR was used to identify potential mediator. Results Our analysis identified significant associations between 22 microbiota taxa and RCC, along with several immune cell traits implicated in RCC modulation by gut microbiota. For instance, Demequinaceae affected RCC through CD14- CD16- AC and CD45 on HLA DR + NK cells. Mediation effect proportions were used to explore the intricate relationships among gut microbiota exposures, immune markers, and their impact on RCC. Conclusion This study reveals the complex interplay between the gut microbiome, immune cells, and RCC. The associations and mediated effects of gut microbiota management for RCC offer valuable insights for future therapeutic strategies.
Bibliographic Details
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know